Robbert W Schouten1, Gertrud L Haverkamp2, Wim L Loosman2, Prataap K Chandie Shaw3, Frans J van Ittersum4, Yves F C Smets5, Louis-Jean Vleming6, Friedo W Dekker7, Adriaan Honig8, Carl E H Siegert5. 1. Department of Nephrology, OLVG, Amsterdam, the Netherlands; Department of Psychiatry, OLVG, Amsterdam, the Netherlands. Electronic address: r.schouten@olvg.nl. 2. Department of Nephrology, OLVG, Amsterdam, the Netherlands; Department of Psychiatry, OLVG, Amsterdam, the Netherlands. 3. Department of Nephrology, Haaglanden Medical Center, The Hague, the Netherlands. 4. Department of Nephrology, VU medical centre, Amsterdam, the Netherlands. 5. Department of Nephrology, OLVG, Amsterdam, the Netherlands. 6. Department of Nephrology, Haga Teaching Hospital, The Hague, the Netherlands. 7. Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, the Netherlands. 8. Department of Psychiatry, OLVG, Amsterdam, the Netherlands.
Abstract
RATIONALE & OBJECTIVE: Anxiety symptoms are common in dialysis patients and have a large impact on quality of life. The association of anxiety symptoms with adverse clinical outcomes in dialysis patients is largely unknown. This study examined the association of anxiety symptoms with hospitalization and mortality in patients receiving maintenance dialysis. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: Maintenance dialysis patients treated at 10 dialysis centers in the Netherlands between 2012 and 2016. EXPOSURES: Time-varying symptoms of anxiety and depression using the Beck Anxiety Inventory and Beck Depression Inventory. OUTCOMES: All-cause mortality, 1-year hospitalization rate, and hospital length of stay. ANALYTICAL APPROACH: Cox proportional hazards and Poisson regression models adjusted for sociodemographic and clinical variables. Sensitivity analyses included multiple imputation of missing data and restriction to incident patients only. RESULTS: 687 patients were included, composed of 433 prevalent and 242 incident dialysis patients. Median follow-up time was 3.1 (IQR, 3.0-3.5) years, during which 172 deaths occurred. 22% of patients had anxiety symptoms and 42% had depressive symptoms. Anxiety symptoms were associated with all-cause mortality and 1-year hospitalization rate and length of stay in all multivariable models. Anxiety symptoms showed a clear dose-response relationship with mortality. LIMITATIONS: Depression and anxiety often coexist and share symptoms. The observational design of this study limits inferences about causal mechanisms between anxiety and clinical outcomes. CONCLUSIONS: Anxiety symptoms are independently associated with increased risk for mortality and 1-year hospitalization. Anxiety symptoms are a clinically relevant risk factor for morbidity and mortality in dialysis patients and warrant further research on effective treatment.
RATIONALE & OBJECTIVE:Anxiety symptoms are common in dialysis patients and have a large impact on quality of life. The association of anxiety symptoms with adverse clinical outcomes in dialysis patients is largely unknown. This study examined the association of anxiety symptoms with hospitalization and mortality in patients receiving maintenance dialysis. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: Maintenance dialysis patients treated at 10 dialysis centers in the Netherlands between 2012 and 2016. EXPOSURES: Time-varying symptoms of anxiety and depression using the Beck Anxiety Inventory and Beck Depression Inventory. OUTCOMES: All-cause mortality, 1-year hospitalization rate, and hospital length of stay. ANALYTICAL APPROACH: Cox proportional hazards and Poisson regression models adjusted for sociodemographic and clinical variables. Sensitivity analyses included multiple imputation of missing data and restriction to incident patients only. RESULTS: 687 patients were included, composed of 433 prevalent and 242 incident dialysis patients. Median follow-up time was 3.1 (IQR, 3.0-3.5) years, during which 172 deaths occurred. 22% of patients had anxiety symptoms and 42% had depressive symptoms. Anxiety symptoms were associated with all-cause mortality and 1-year hospitalization rate and length of stay in all multivariable models. Anxiety symptoms showed a clear dose-response relationship with mortality. LIMITATIONS: Depression and anxiety often coexist and share symptoms. The observational design of this study limits inferences about causal mechanisms between anxiety and clinical outcomes. CONCLUSIONS:Anxiety symptoms are independently associated with increased risk for mortality and 1-year hospitalization. Anxiety symptoms are a clinically relevant risk factor for morbidity and mortality in dialysis patients and warrant further research on effective treatment.
Authors: Loan T Dang; Thuc C Luong; Dung H Nguyen; Trung A Hoang; Hoai T Nguyen; Hoang C Nguyen; Thai H Duong; Tu T Tran; Linh V Pham; Tuan V Ngo; Hoi T Nguyen; Nga T Trieu; Thinh V Do; Manh V Trinh; Tung H Ha; Dung T Phan; Binh N Do; Shwu-Huey Yang; Tsae-Jyy Wang; Tuyen Van Duong Journal: Nutrients Date: 2022-06-07 Impact factor: 6.706
Authors: Els Nadort; Robbert W Schouten; Friedo W Dekker; Adriaan Honig; Patricia van Oppen; Carl E H Siegert Journal: BMC Psychiatry Date: 2019-11-27 Impact factor: 3.630
Authors: Xueqing Yu; Masaaki Nakayama; Mai-Szu Wu; Yong-Lim Kim; Lily Mushahar; Cheuk Chun Szeto; Dori Schatell; Fredric O Finkelstein; Robert R Quinn; Michelle Duddington Journal: Kidney Int Rep Date: 2021-10-30
Authors: C G N Voorend; M van Oevelen; M Nieberg; Y Meuleman; C F M Franssen; H Joosten; N C Berkhout-Byrne; A C Abrahams; S P Mooijaart; W J W Bos; M van Buren Journal: BMC Geriatr Date: 2021-11-19 Impact factor: 3.921
Authors: Ivana Skoumalova; Andrea Madarasova Geckova; Jaroslav Rosenberger; Maria Majernikova; Peter Kolarcik; Daniel Klein; Andrea F de Winter; Jitse P van Dijk; Sijmen A Reijneveld Journal: Int J Environ Res Public Health Date: 2020-10-28 Impact factor: 3.390
Authors: Carlos J Delgado-Domínguez; Sergio Sanz-Gómez; Ana López-Herradón; Beatriz Díaz Espejo; Olaya Lamas González; Macarena de Los Santos Roig; Isabel Berdud Godoy; Abraham Rincón Bello; Rosa Ramos Sánchez Journal: Int J Environ Res Public Health Date: 2021-03-29 Impact factor: 3.390